1
|
de Juan Ferré A, Álvarez Álvarez R, Casado Herráez A, Cruz Jurado J, Estival González A, Martín-Broto J, Martínez Marín V, Moreno Vega A, Sebio García A, Valverde Morales C. SEOM Clinical Guideline of management of soft-tissue sarcoma (2020). Clin Transl Oncol 2021; 23:922-930. [PMID: 33405052 PMCID: PMC8057970 DOI: 10.1007/s12094-020-02534-0] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Accepted: 11/21/2020] [Indexed: 02/06/2023]
Abstract
Soft-tissue sarcomas constitute an uncommon and heterogeneous group of tumors of mesenchymal origin. Diagnosis, treatment, and management should be performed by an expert multidisciplinary team. MRI/CT of the primary tumor and biopsy is mandatory before any treatment. Wide surgical resection with tumor-free tissue margin is the mainstay for localized disease. Radiotherapy is indicated in large, deep, high-grade tumors, or after marginal resection not suitable for re-excision. Perioperative chemotherapy should be discussed for high-risk sarcomas of the extremities and trunk-wall. In the case of oligometastatic disease, patients should be considered for local therapies. First-line treatment with anthracyclines (or in combination with ifosfamide) is the treatment of choice. Other drugs have shown activity in second-line therapy and in specific histological subtypes but options are limited and thus, a clinical trial should always be discussed.
Collapse
|
2
|
Hindi N, Fernandez-Serra A, Martinez-Trufero J, Carranza-Carranza A, Lopez-Pousa A, Lavernia J, Arranz J, López Alegret R, Martinez-Garcia J, Valverde Morales C, Cano J, Vaz M, Moura D, Bagué S, Gonzalez-Campora R, Lopez-Guerrero J, Martin-Broto J. Analysis of expression of immunomodulation factors in alveolar soft-part sarcoma: a retrospective study from the Spanish Group for Research on Sarcoma (GEIS). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx387.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
3
|
Kasper B, Casali P, Drove N, Dumont S, Eriksson M, Gronchi A, Lecointe E, Valverde Morales C, Wilson R, Boldon S, Wait S, Wartenberg M. The sarcoma policy checklist: Focusing policy efforts on sarcoma. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx387.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
4
|
Serrano C, Lopez Pousa A, Pajares I, Valverde Morales C, Duran J, Rubió-Casadevall J, Safont M, Martinez V, Díaz Beveridge R, Estival A, Vicente Baz D, Sebio Garcia A, Hindi N, Landolfi S, Olivares D, Garcia-Valverde A, Ledesma P, Arribas J, Carles Galceran J, Martin Broto J. Clinicopathologic features and long-term follow-up of metastatic gastrointestinal stromal tumor (GIST) patients (pts) with durable response (≥ 5 years) to frontline imatinib (IM): A case-control study from GEIS. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx387.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
5
|
Redondo A, Morales CV, Hindi N, Lopez-Martin J, Honigschmidt G, Zeng Y, Chen J, Tai D, Mo G, Ilaria R, Pillay N, Drove N, Jamarik M. ANNOUNCE 2: An open-label phase 1b, and a randomized, double-blind phase 2 study of olaratumab with gemcitabine plus docetaxel in the treatment of patients with advanced soft tissue sarcoma (STS). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw388.26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
6
|
Luengo M, Hervás D, Sobrevilla N, Muro XG, Padro JGI, Castellano D, Aparicio J, Muñoz AS, Buxo E, Saenz A, Aguilar J, Valverde Morales C, Fernández Aramburu A, Maroto P, Espinosa M, Fonseca PJ, Ros S, Margeli M, Sastre J, Gonzalez-Billalabeitia E. A risk assessment model for predicting venous thromboembolic events in chemotherapy-treated germ-cell cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw390.48] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Cruz Jurado J, Valverde Morales C, Vaz M, Alvarez Alvarez R, Lopez-Pousa A, Sancho Marquez P, Carrasco J, Martinez-Trufero J, Sala Gonzalez M, Arranz J, De Sande González L, Blanco Sanchez M, Orbegoso C, Pérez-Fidalgo J, Martinez García J, Lavernia J, Sevilla I, Cano J, Meana A, Martin Broto J. Solitary Fibrous Tumor (Sft): a Registry Program to Assess Frequency and Managemente in Our Country. a Spanish Group for Research on Sarcoma (Geis) Study. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu354.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
8
|
Joensuu H, Blay JY, Comandone A, Martin Broto J, Fumagalli E, Grignani G, Garcia Del Muro X, Adenis A, Valverde Morales C, Lopez Pousa A, Bouché O, Bui B, Bauer S, Barone C, Weiss C, Crippa S, Camozzi M, Castellana R, Le Cesne A. Phase 2 Trial to Evaluate the Efficacy and Safety of Dovitinib in Patients (Pts) with Gastrointestinal Stromal Tumor (Gist) Refractory and/or Intolerant to Imatinib (Im). Ann Oncol 2014. [DOI: 10.1093/annonc/mdu438.58] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
9
|
Martinez-Trufero J, Alvarez Alvarez R, Lopez Pousa A, Sevilla I, Sancho Marquez P, Orbegoso C, Cruz Jurado J, Sala Gonzalez M, Valverde Morales C, Blanco Sanchez M, Pérez-Fidalgo J, Berros J, Martinez García J, Arranz J, Meana A, López-Martín J, Rubió J, Cano J, Juez-Martel I, Martin Broto J. Multidisciplinary Treatment Outcome of Desmoid-Type Fibromatosis (Dtf). a Registry-Based Study from Spanish Group for Research on Sarcoma (Geis). Ann Oncol 2014. [DOI: 10.1093/annonc/mdu354.41] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Martin Broto J, Calabuig S, Rubio J, Gutierrez A, Duran J, Garcia F, Martinez-Trufero J, Maurel J, García Del Muro X, Cruz J, Cubedo R, Poveda A, Valverde Morales C, De Sande González L, De Juan A, Lopez-Guerrero J. Integrating Genotype in Risk Classification for Gist Recurrence. a Spanish Group for Sarcoma Research (Geis) Study. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu354.5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Maurel J, Lopez-Pousa A, Calabuig S, Bagué S, Del Muro XG, Sanjuan X, Rubió J, Cuatrecasas M, Martinez-Trufero J, Horndler C, Fra J, Morales CV, Redondo A, Poveda A, Sevilla I, Lainez N, Rubini M, Albéniz XG, Broto JM, De Álava E. Prognosis of Phosphorylated-Insulin Growth Factor Receptor (P-Igf-1R) and Metalloproteinase-3 (Mmp3) Expression in Advanced Gastrointestinal Stromal Tumors (Gist) Patients Treated with Imatinib. a Geis Study. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu326.61] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Castro DT, De Torres I, Sánchez-Ollé G, Maldonado X, Morales-Barrera R, Suarez C, Morales CV, Hernandez IN, Morote J, Carles J. c-MYC Expression is Modulated by Statins Use and it's Correlated with Time to Progression (TTP) in Men with Localised Prostate Cancer Treated with Radical Radiotherapy. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33474-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
13
|
Arnedo JS, Marín SDH, Morales CV, Pastor RP. [Description of the intensive care unit of the Alicante University General Hospital]. Enferm Intensiva 1996; 7:83-90. [PMID: 8949060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|